Hepatitis C virus related lymphoproliferative disorder in a renal transplant recipient
β Scribed by A. N. Aravindan; Venkatesh Moger; Vinay Sakhuja; Harbir S. Kohli; Neelam Varma; Vivekanand Jha
- Publisher
- Springer Netherlands
- Year
- 2006
- Tongue
- English
- Weight
- 93 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0301-1623
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
with treatment failures moving on to combination therapy (IFN/CMB). The primary difference between the two best strategies (IFN/CBM vs. CMB-G) was that the CMB-G strategy was more successful with those with genotype 1. Thus, the genotyping strategy reached more people with less responsive disease th
Fibrosing cholestatic hepatitis (FCH) has been described as a specific manifestation of hepatitis B virus (HBV) infection in liver allograft recipients characterized by a rapid progression to liver failure. Only sporadic cases have been reported in other immunocompromised groups infected with HBV an
## Background: Localized hepatic post-transplant lymphoproliferative disease is uncommon. in such cases, lymphocyte epstein-barr virus (ebv) infection may promote an intrahepatic b-lymphocyte monoclonal expansion. ## Methods: From 1990 to 1991, 149 patients underwent liver transplantation for var